insights_auto
Outlook: 75.0% bullish·0.0% bearish
Go to analysischevron_right
PGEN:NASDAQ
Precigen Inc
$7.81
arrow_upward
+0.77%(+0.060) 1D
$7.82
arrow_upward
+0.13% (+0.010)bedtimeAfter hours
Closed: Sep 28, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PGEN...
Open
$7.61
High
$7.86
Low
$7.50
Mkt. cap
2.80B
Avg. vol.
4.87M
Volume
3.49M
52-wk high
$8.26
52-wk low
$2.99
EPS
-$1.10
Beta
1.02
Shares outstanding
358.04M
No. of employees
160
Open
$7.61
High
$7.86
Low
$7.50
Mkt. cap
2.80B
Avg. vol.
4.87M
Volume
3.49M
52-wk high
$8.26
52-wk low
$2.99
EPS
-$1.10
Beta
1.02
Shares outstanding
358.04M
No. of employees
160
News stories
From web sources and news partners
Zacks
·
6 hours ago
FDA Expands Merck's Welireg Label for a New Kidney Cancer Indication
Zacks
·
6 hours ago
MIRM Secures FDA Nod for an Ultra-Rare Bone Disorder Therapy
Zacks
·
7 hours ago
LLY's Olumiant Gets FDA Nod for Expanded Use in Pediatric Hair Loss
Stock Traders Daily
·
16 hours ago
(PGEN) Movement as an Input in Quant Signal Sets
Profile
Precigen, Inc. is an American biotechnology company. Its president and CEO is Helen Sabzevari.
Intrexon was founded in 1998, and is headquartered in Germantown, Maryland. With a suite of proprietary and complementary technologies, Intrexon applies engineering to biological systems to enable DNA-based control over the function and output of living cells. Wikipedia
About Precigen Inc
CEOHelen Sabzevari
Employees160
FoundedMay 21, 1998
Headquarters-
SectorBiotechnology
Websiteprecigen.com